Mickie Cheng
Endocrinology, Diabetes & Metabolism · San Francisco, CANPI 1053581306
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,718 of the $3,589 with a category attached, or 75.7%. 16 manufacturers reported payments, led by Eli Lilly at 32.7% of the total. Reporting peaked in 2019 at $2,172 and has fallen 80.0% since, to $435 in 2021.
Across 110 payments — averaging $32.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$1K
- Amgen$940
- Lilly USA, LLC$363
- Radius Health, Inc.$234
- Novo Nordisk$155
- Tandem Diabetes Care, Inc.$140
- plus $582 from 10 others
Across 7 payments — averaging $18,072 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$87K
- Lexicon Pharmaceuticals, Inc.$39K
What the payments were for
- Travel & lodging$86324%
- Food & beverage$2,71876%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 4 | $1,174 |
| Amgen | 41 | $940 |
| Lilly USA, LLC | 19 | $363 |
| Radius Health, Inc. | 12 | $234 |
| Novo Nordisk | 9 | $155 |
| Tandem Diabetes Care, Inc. | 2 | $140 |
| Boehringer Ingelheim | 6 | $123 |
| Janssen Scientific Affairs, LLC | 1 | $123 |
| AstraZeneca(2 entities) | 5 | $100 |
| GSK | 3 | $57 |
| Companion Medical, Inc. | 2 | $54 |
| Sanofi-aventis U.S. LLC | 2 | $44 |
| Astellas Pharma US Inc | 1 | $24 |
| Shire North American Group Inc | 1 | $23 |
| Insulet Corporation | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- t-slim insulin pump$139
- INVOKANA$123
How this compares
$3,589 in reported general payments places this provider in the 65th percentile of 952 endocrinology, diabetes & metabolism providers in California.
See all endocrinology, diabetes & metabolism providers in California →
Other endocrinology, diabetes & metabolism in San Francisco
- Cheng Yang TuanSan Francisco$568K
- Lewis BlevinsSan Francisco$166K
- Wade AubrySan Francisco$79K
- Marc HellersteinSan Francisco$56K
- Juan FriasSan Diego$1.4M
- Joselito CabaccanSan Jose$1.4M
- Daniel NadeauNewport Beach$1.2M
- Yehuda HandelsmanTarzana$1M
- Helen BaronRancho Mirage$958K
- Ken FujiokaSan Diego$747K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.